Cardiovascular diseases continue today in Cuba as the first cause of death and of economic and labor impact on society, according to Dr. Eduardo Rivas, president of the Cuban Society of Cardiology.
The HeberFERON, a Cuban medicine for the treatment of basal cell carcinoma (CBC), has benefited over 200 patients with very favorable prognoses, since the beginning of this medical procedure in the province of Holguin, in 20l6.
Read more Effectiveness of Cuban Medication HEBERPAG in Holguin



Page 170 of 486